+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum

Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum

Antimicrobial Agents and ChemoTherapy 48(6): 1989-1992

The possible reactivities of commonly used antibiotics of fungal, nonfungal, and nonmicrobial or synthetic sources with the Platelia Aspergillus galactomannan assay were assessed. For drugs that tested positive, the minimal concentration of the antibiotic in serum that yielded a positive test (index, >0.5) was determined. At undiluted concentrations, piperacillin and multiple lots of piperacillin-tazobactam tested positive, whereas amoxicillin, ampicillin-sulbactam, nafcillin, cefazolin, ceftazidime, erythromycin, gentamicin, and levofloxacin tested negative. All three lots of piperacillin-tazobactam and all bags within each lot tested positive, with a mean index value of 5.168. At achievable concentrations in serum, however, only one of three lots of piperacillin-tazobactam yielded a positive test. Concentrations of 75, 150, and 300 microg/ml of serum tested positive with the Platelia Aspergillus enzyme immunoassay, whereas lower concentrations, mimicking the trough levels, tested negative. Thus, while achievable serum piperacillin-tazobactam concentrations may potentially result in a positive test for galactomannan, the timing of the collection of serum samples from patients may influence the test results, with reactivity being less likely in samples collected at trough levels or prior to the administration of a dose of the antibiotic.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 012485590

Download citation: RISBibTeXText

PMID: 15155189

DOI: 10.1128/aac.48.6.1989-1992.2004

Related references

False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?. Journal of Antimicrobial ChemoTherapy 62(5): 1109-1112, 2008

False-positive results in the galactomannan Platelia™ Aspergillus assay with generic piperacillin/tazobactam. Revista Iberoamericana de Micologia 2019, 2019

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clinical Infectious Diseases 38(6): 913-916, 2004

False positive galactomannan Platelia due to piperacillin-tazobactam. Medecine et Maladies Infectieuses 42(1): 10-14, 2012

Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clinical Infectious Diseases 39(9): 1401-2; Author Reply 1402-3, 2004

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clinical Infectious Diseases 38(6): 917-920, 2004

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. Journal of Clinical Microbiology 52(6): 2199-2201, 2015

Aspergillus galactomannan antigen detection with Platelia Aspergillus: Multiple positive antigenemia without Aspergillus infection. Journal de Mycologie Medicale 8(2): 112-113, 1998

The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over?. Infection 41(1): 293-294, 2013

Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clinical and Vaccine Immunology 15(12): 1760-1763, 2008

Lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen. Transplant Infectious Disease 14(1): 107-109, 2012

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. Journal of Clinical Microbiology 42(10): 4744-4748, 2004

Treatment with piperacillin-tazobactam and Aspergillus galactomannan test results for patients with hematological malignancies. European Journal of Internal Medicine 18(1): 79, 2007

Reproducibility of positive results for the detection of serum galactomannan by Platelia™ aspergillus EIA. Mycopathologia 176(3-4): 295-297, 2014

Repeating the Platelia™ Aspergillus test in samples positive for serum galactomannan: Is it necessary?. Revista Iberoamericana de Micologia 32(3): 204-207, 2016